- Record: found
- Abstract: not found
- Article: not found
A phase II study of futibatinib (TAS-120) in patients (pts) with advanced (adv) solid tumors harboring fibroblast growth factor receptor (FGFR) genomic aberrations
A. Hollebecque, T. DOI, O Saavedra, O Takahashi, H. HE, KA Benhadji, O SAAVEDRA, Antoine Hollebecque, Toshihiko Doi, Omar Saavedra, Osamu Takahashi, Helen He, Karim A. Benhadji, Kohei Shitara, T Doi
2020
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.